ARTICLE | Clinical News
EMEA to review CTIC's Trisenox MAA
February 2, 2001 8:00 AM UTC
Cell Therapeutics (CTIC) said that the CPMP accepted for review its MAA for Trisenox arsenic trioxide to treat relapsed acute promyelocytic leukemia (APL). Trisenox is approved to treat relapsed or re...